MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • 2024 International Congress

    Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

    Objective: The aim of our study was to observe the clinical characteristics of different movement disorders (MD) in patients with multiple sclerosis (MS). Background: Demyelinating…
  • 2024 International Congress

    CAPRIN1 defect: a new severe neurodegenerative disorder with childhood dementia, myoclonus-ataxia, and sensorimotor neuropathy

    R. Bove, A. Torella, G. Ricciardi, L. Pollini, M. Novelli, F. Pisani, V. Nigro, V. Leuzzi, S. Galosi (Rome, Italy)

    Objective: To present the case of a patient with a severe neurodegenerative disorder with onset in pediatric age carrying a pathogenic variant in CAPRIN1 gene…
  • 2024 International Congress

    Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients

    M. Tosin, D. Hall, L. Quinchia (Chicago, USA)

    Objective: Determine the rate of progression of motor signs in fragile X-associated tremor/ataxia syndrome (FXTAS) over a one-year follow-up. Background: Limited information exists regarding the…
  • 2024 International Congress

    Clinico-radiological and genetic profile of patients with Ataxia with Oculomotor apraxia type-2 (AOA2)- A case series from India

    M. Chandarana, B. Tilva, A. Agarwal, D. Garg (Ahmedabad, India)

    Objective: To delineate clinical, radiological and genetic profile of patients with ataxia with oculomotor apraxia type-2 (AOA2) in Indian cohort. Background: AOA2 is a relatively…
  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    paraneoplastic cerebellar ataxia: a rare cause of late-onset ataxia

    H. Boussaid, R. Zouari, D. Ben Mohamed, A. Rachdi, Z. Said, F. Nebli, S. Ben Sassi (monastir, Tunisia)

    Objective: investigate the clinical features, imaging findings and immunological characteristics of Paraneoplastic cerebellar ataxia (PCA) in our cohort. Background: Paraneoplastic cerebellar ataxia (PCA) is a…
  • 2024 International Congress

    Spectrum of polysomnographic abnormalities in a cohort of sporadic late onset ataxia patients

    A. Das, A. Jaryal, A. Srivastava (New Delhi, India)

    Objective: To evaluate the occurrence of rapid eye movement behavioral disorder (RBD) and associated polysomnographic abnormalities in patients of sporadic adult onset ataxia Background: Sporadic…
  • 2024 International Congress

    Movement disorders secondary to neurocysticercosis: a case report from Bolivia

    M. Jauregui, S. Silva, P. Chana-Cuevas, P. Salles (La Paz, Bolivia)

    Objective: The objective is the presentation of a movement disorder related to Taenia solium infection that produces neurocysticercosis. Background: The incidence of neurocysticercosis in Bolivia…
  • 2024 International Congress

    Novel Partial Gene Deletion in CaCNA1A Presenting with Gait Ataxia, Vertigo, and Abnormal Eye Movements

    D. Mohanty, I. Bledsoe (San Francisco, USA)

    Objective: To report a partial gene deletion in CaCNA1A associated with ataxia. Background: CaCNA1A gene, located on chromosome 19p, encodes the alpha-1a subunit of the…
  • 2024 International Congress

    Volatile solvent abuse and Cerebellar ataxia: A case series

    J. Ganguly, S. Jha, N. Pandita, S. Mukherjee, N. Singh, H. Kumar (Kolkata, India)

    Objective: Delineation of clinical and radiological features of cerebellar ataxia from volatile solvent abuse. Background: Volatile solvents like glues, correction fluid, acrylic paints, varnishes, lacquers…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 27
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley